Drospirenone/Ethinyl Estradiol (Gianvi®)
R06-0632
Phase 1 small_molecule completed
Quick answer
Drospirenone/Ethinyl Estradiol (Gianvi®) for Healthy is a Phase 1 program (small_molecule) at Teva Pharma GmbH with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Teva Pharma GmbH
- Indication
- Healthy
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed